ANDREA HOLZMAN: Open Payments
NPI 1760903173 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 55 payments from 14 companies in 2025. Trend: 2023 $989 · 2024 $1,395 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $245 |
| PFIZER INC. | 10 | $184 |
| AstraZeneca Pharmaceuticals LP | 5 | $116 |
| Lilly USA, LLC | 4 | $86 |
| Abbott Laboratories | 4 | $82 |
| GlaxoSmithKline, LLC. | 4 | $81 |
| Astellas Pharma US Inc | 3 | $71 |
| ABBVIE INC. | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
Products named: Ozempic, JARDIANCE, NURTEC ODT, FREESTYLE LIBRE 3, Veozah, BREZTRI, TRELEGY ELLIPTA, ELIQUIS.
Industry payments across MD — which companies pay providers there.
